Aplastic Anemia and Other Bone Marrow Failure Syndromes:
During the past decade, there have been numerous direct and indirect scientific contributions to both the etiology and therapy of aplastic anemia and related bone marrow failure syndromes. Clinical observations, such as autologous bone marrow recovery after conditioning with immunosup pressive agen...
Gespeichert in:
Weitere Verfasser: | |
---|---|
Format: | Elektronisch E-Book |
Sprache: | English |
Veröffentlicht: |
New York, NY
Springer New York
1990
|
Schlagworte: | |
Online-Zugang: | UBR01 Volltext |
Zusammenfassung: | During the past decade, there have been numerous direct and indirect scientific contributions to both the etiology and therapy of aplastic anemia and related bone marrow failure syndromes. Clinical observations, such as autologous bone marrow recovery after conditioning with immunosup pressive agents for bone marrow transplantation; failure to achieve en graftment in some identical twins without prior immunosuppressive ther apy; and hematologic response to immunosuppressive agents, have led to the concept of immune-mediated etiology of acquired aplastic anemia. Such a concept was further strengthened by laboratory findings, implicat ing the role of activated cytotoxic T lymphocytes and abnormal produc tion of inhibitory lymphokines. The immunologic mechanisms may also apply to the idiosyncratic bone marrow aplasias associated with drugs, toxic chemicals, and viruses. These agents may alter normal cellular recog nition sites by interacting with cellular components and result in loss of self tolerance. Immunologic mechanisms have long been advocated in many other organ failures, and the hemopoietic organ is no exception. It is of interest that parallel clinical and laboratory investigations in juvenile diabetes mellitus type I and in rodent models of this disease have yielded results compatible with the same pathogenic mechanisms. The infiltration of pancreatic islets by activated T lymphocytes, functional and morphological alterations of islet cells upon incubation with lymphokines such as gamma interferon and tumor necrosis factor, and clinical response to cyclosporine are a few examples |
Beschreibung: | 1 Online-Ressource (XVII, 236 p) |
ISBN: | 9781461232544 |
DOI: | 10.1007/978-1-4612-3254-4 |
Internformat
MARC
LEADER | 00000nmm a2200000zc 4500 | ||
---|---|---|---|
001 | BV046146340 | ||
003 | DE-604 | ||
005 | 00000000000000.0 | ||
007 | cr|uuu---uuuuu | ||
008 | 190905s1990 |||| o||u| ||||||eng d | ||
020 | |a 9781461232544 |9 978-1-4612-3254-4 | ||
024 | 7 | |a 10.1007/978-1-4612-3254-4 |2 doi | |
035 | |a (ZDB-2-SME)978-1-4612-3254-4 | ||
035 | |a (OCoLC)1119103414 | ||
035 | |a (DE-599)BVBBV046146340 | ||
040 | |a DE-604 |b ger |e aacr | ||
041 | 0 | |a eng | |
049 | |a DE-355 | ||
082 | 0 | |a 616.15 |2 23 | |
084 | |a YC 2400 |0 (DE-625)153201:12905 |2 rvk | ||
245 | 1 | 0 | |a Aplastic Anemia and Other Bone Marrow Failure Syndromes |c edited by Nasrollah T. Shahidi |
264 | 1 | |a New York, NY |b Springer New York |c 1990 | |
300 | |a 1 Online-Ressource (XVII, 236 p) | ||
336 | |b txt |2 rdacontent | ||
337 | |b c |2 rdamedia | ||
338 | |b cr |2 rdacarrier | ||
520 | |a During the past decade, there have been numerous direct and indirect scientific contributions to both the etiology and therapy of aplastic anemia and related bone marrow failure syndromes. Clinical observations, such as autologous bone marrow recovery after conditioning with immunosup pressive agents for bone marrow transplantation; failure to achieve en graftment in some identical twins without prior immunosuppressive ther apy; and hematologic response to immunosuppressive agents, have led to the concept of immune-mediated etiology of acquired aplastic anemia. Such a concept was further strengthened by laboratory findings, implicat ing the role of activated cytotoxic T lymphocytes and abnormal produc tion of inhibitory lymphokines. The immunologic mechanisms may also apply to the idiosyncratic bone marrow aplasias associated with drugs, toxic chemicals, and viruses. These agents may alter normal cellular recog nition sites by interacting with cellular components and result in loss of self tolerance. Immunologic mechanisms have long been advocated in many other organ failures, and the hemopoietic organ is no exception. It is of interest that parallel clinical and laboratory investigations in juvenile diabetes mellitus type I and in rodent models of this disease have yielded results compatible with the same pathogenic mechanisms. The infiltration of pancreatic islets by activated T lymphocytes, functional and morphological alterations of islet cells upon incubation with lymphokines such as gamma interferon and tumor necrosis factor, and clinical response to cyclosporine are a few examples | ||
650 | 4 | |a Hematology | |
650 | 4 | |a Oncology | |
650 | 4 | |a Pediatrics | |
650 | 4 | |a Allergology | |
650 | 4 | |a Immunology | |
650 | 4 | |a Cell Biology | |
650 | 4 | |a Hematology | |
650 | 4 | |a Oncology | |
650 | 4 | |a Pediatrics | |
650 | 4 | |a Allergy | |
650 | 4 | |a Immunology | |
650 | 4 | |a Cytology | |
650 | 0 | 7 | |a Aplastische Anämie |0 (DE-588)4228474-0 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Knochenmarkkrankheit |0 (DE-588)4228476-4 |2 gnd |9 rswk-swf |
655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |y 1987 |z Washington DC |2 gnd-content | |
689 | 0 | 0 | |a Aplastische Anämie |0 (DE-588)4228474-0 |D s |
689 | 0 | |5 DE-604 | |
689 | 1 | 0 | |a Knochenmarkkrankheit |0 (DE-588)4228476-4 |D s |
689 | 1 | |5 DE-604 | |
700 | 1 | |a Shahidi, Nasrollah T. |4 edt | |
776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9781461279358 |
776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9780387970301 |
776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9781461232551 |
856 | 4 | 0 | |u https://doi.org/10.1007/978-1-4612-3254-4 |x Verlag |z URL des Erstveröffentlichers |3 Volltext |
912 | |a ZDB-2-SME | ||
940 | 1 | |q ZDB-2-SME_1990/2004 | |
999 | |a oai:aleph.bib-bvb.de:BVB01-031526525 | ||
966 | e | |u https://doi.org/10.1007/978-1-4612-3254-4 |l UBR01 |p ZDB-2-SME |q ZDB-2-SME_1990/2004 |x Verlag |3 Volltext |
Datensatz im Suchindex
_version_ | 1804180484196925440 |
---|---|
any_adam_object | |
author2 | Shahidi, Nasrollah T. |
author2_role | edt |
author2_variant | n t s nt nts |
author_facet | Shahidi, Nasrollah T. |
building | Verbundindex |
bvnumber | BV046146340 |
classification_rvk | YC 2400 |
collection | ZDB-2-SME |
ctrlnum | (ZDB-2-SME)978-1-4612-3254-4 (OCoLC)1119103414 (DE-599)BVBBV046146340 |
dewey-full | 616.15 |
dewey-hundreds | 600 - Technology (Applied sciences) |
dewey-ones | 616 - Diseases |
dewey-raw | 616.15 |
dewey-search | 616.15 |
dewey-sort | 3616.15 |
dewey-tens | 610 - Medicine and health |
discipline | Medizin |
doi_str_mv | 10.1007/978-1-4612-3254-4 |
format | Electronic eBook |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03776nmm a2200625zc 4500</leader><controlfield tag="001">BV046146340</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">190905s1990 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781461232544</subfield><subfield code="9">978-1-4612-3254-4</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/978-1-4612-3254-4</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-2-SME)978-1-4612-3254-4</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1119103414</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV046146340</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.15</subfield><subfield code="2">23</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">YC 2400</subfield><subfield code="0">(DE-625)153201:12905</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Aplastic Anemia and Other Bone Marrow Failure Syndromes</subfield><subfield code="c">edited by Nasrollah T. Shahidi</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">New York, NY</subfield><subfield code="b">Springer New York</subfield><subfield code="c">1990</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (XVII, 236 p)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">During the past decade, there have been numerous direct and indirect scientific contributions to both the etiology and therapy of aplastic anemia and related bone marrow failure syndromes. Clinical observations, such as autologous bone marrow recovery after conditioning with immunosup pressive agents for bone marrow transplantation; failure to achieve en graftment in some identical twins without prior immunosuppressive ther apy; and hematologic response to immunosuppressive agents, have led to the concept of immune-mediated etiology of acquired aplastic anemia. Such a concept was further strengthened by laboratory findings, implicat ing the role of activated cytotoxic T lymphocytes and abnormal produc tion of inhibitory lymphokines. The immunologic mechanisms may also apply to the idiosyncratic bone marrow aplasias associated with drugs, toxic chemicals, and viruses. These agents may alter normal cellular recog nition sites by interacting with cellular components and result in loss of self tolerance. Immunologic mechanisms have long been advocated in many other organ failures, and the hemopoietic organ is no exception. It is of interest that parallel clinical and laboratory investigations in juvenile diabetes mellitus type I and in rodent models of this disease have yielded results compatible with the same pathogenic mechanisms. The infiltration of pancreatic islets by activated T lymphocytes, functional and morphological alterations of islet cells upon incubation with lymphokines such as gamma interferon and tumor necrosis factor, and clinical response to cyclosporine are a few examples</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Hematology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Oncology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pediatrics</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Allergology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Immunology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cell Biology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Hematology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Oncology </subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pediatrics</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Allergy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Immunology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cytology</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Aplastische Anämie</subfield><subfield code="0">(DE-588)4228474-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Knochenmarkkrankheit</subfield><subfield code="0">(DE-588)4228476-4</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="y">1987</subfield><subfield code="z">Washington DC</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Aplastische Anämie</subfield><subfield code="0">(DE-588)4228474-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Knochenmarkkrankheit</subfield><subfield code="0">(DE-588)4228476-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Shahidi, Nasrollah T.</subfield><subfield code="4">edt</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9781461279358</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9780387970301</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9781461232551</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1007/978-1-4612-3254-4</subfield><subfield code="x">Verlag</subfield><subfield code="z">URL des Erstveröffentlichers</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-2-SME</subfield></datafield><datafield tag="940" ind1="1" ind2=" "><subfield code="q">ZDB-2-SME_1990/2004</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-031526525</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1007/978-1-4612-3254-4</subfield><subfield code="l">UBR01</subfield><subfield code="p">ZDB-2-SME</subfield><subfield code="q">ZDB-2-SME_1990/2004</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
genre | (DE-588)1071861417 Konferenzschrift 1987 Washington DC gnd-content |
genre_facet | Konferenzschrift 1987 Washington DC |
id | DE-604.BV046146340 |
illustrated | Not Illustrated |
indexdate | 2024-07-10T08:36:29Z |
institution | BVB |
isbn | 9781461232544 |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-031526525 |
oclc_num | 1119103414 |
open_access_boolean | |
owner | DE-355 DE-BY-UBR |
owner_facet | DE-355 DE-BY-UBR |
physical | 1 Online-Ressource (XVII, 236 p) |
psigel | ZDB-2-SME ZDB-2-SME_1990/2004 ZDB-2-SME ZDB-2-SME_1990/2004 |
publishDate | 1990 |
publishDateSearch | 1990 |
publishDateSort | 1990 |
publisher | Springer New York |
record_format | marc |
spelling | Aplastic Anemia and Other Bone Marrow Failure Syndromes edited by Nasrollah T. Shahidi New York, NY Springer New York 1990 1 Online-Ressource (XVII, 236 p) txt rdacontent c rdamedia cr rdacarrier During the past decade, there have been numerous direct and indirect scientific contributions to both the etiology and therapy of aplastic anemia and related bone marrow failure syndromes. Clinical observations, such as autologous bone marrow recovery after conditioning with immunosup pressive agents for bone marrow transplantation; failure to achieve en graftment in some identical twins without prior immunosuppressive ther apy; and hematologic response to immunosuppressive agents, have led to the concept of immune-mediated etiology of acquired aplastic anemia. Such a concept was further strengthened by laboratory findings, implicat ing the role of activated cytotoxic T lymphocytes and abnormal produc tion of inhibitory lymphokines. The immunologic mechanisms may also apply to the idiosyncratic bone marrow aplasias associated with drugs, toxic chemicals, and viruses. These agents may alter normal cellular recog nition sites by interacting with cellular components and result in loss of self tolerance. Immunologic mechanisms have long been advocated in many other organ failures, and the hemopoietic organ is no exception. It is of interest that parallel clinical and laboratory investigations in juvenile diabetes mellitus type I and in rodent models of this disease have yielded results compatible with the same pathogenic mechanisms. The infiltration of pancreatic islets by activated T lymphocytes, functional and morphological alterations of islet cells upon incubation with lymphokines such as gamma interferon and tumor necrosis factor, and clinical response to cyclosporine are a few examples Hematology Oncology Pediatrics Allergology Immunology Cell Biology Oncology Allergy Cytology Aplastische Anämie (DE-588)4228474-0 gnd rswk-swf Knochenmarkkrankheit (DE-588)4228476-4 gnd rswk-swf (DE-588)1071861417 Konferenzschrift 1987 Washington DC gnd-content Aplastische Anämie (DE-588)4228474-0 s DE-604 Knochenmarkkrankheit (DE-588)4228476-4 s Shahidi, Nasrollah T. edt Erscheint auch als Druck-Ausgabe 9781461279358 Erscheint auch als Druck-Ausgabe 9780387970301 Erscheint auch als Druck-Ausgabe 9781461232551 https://doi.org/10.1007/978-1-4612-3254-4 Verlag URL des Erstveröffentlichers Volltext |
spellingShingle | Aplastic Anemia and Other Bone Marrow Failure Syndromes Hematology Oncology Pediatrics Allergology Immunology Cell Biology Oncology Allergy Cytology Aplastische Anämie (DE-588)4228474-0 gnd Knochenmarkkrankheit (DE-588)4228476-4 gnd |
subject_GND | (DE-588)4228474-0 (DE-588)4228476-4 (DE-588)1071861417 |
title | Aplastic Anemia and Other Bone Marrow Failure Syndromes |
title_auth | Aplastic Anemia and Other Bone Marrow Failure Syndromes |
title_exact_search | Aplastic Anemia and Other Bone Marrow Failure Syndromes |
title_full | Aplastic Anemia and Other Bone Marrow Failure Syndromes edited by Nasrollah T. Shahidi |
title_fullStr | Aplastic Anemia and Other Bone Marrow Failure Syndromes edited by Nasrollah T. Shahidi |
title_full_unstemmed | Aplastic Anemia and Other Bone Marrow Failure Syndromes edited by Nasrollah T. Shahidi |
title_short | Aplastic Anemia and Other Bone Marrow Failure Syndromes |
title_sort | aplastic anemia and other bone marrow failure syndromes |
topic | Hematology Oncology Pediatrics Allergology Immunology Cell Biology Oncology Allergy Cytology Aplastische Anämie (DE-588)4228474-0 gnd Knochenmarkkrankheit (DE-588)4228476-4 gnd |
topic_facet | Hematology Oncology Pediatrics Allergology Immunology Cell Biology Oncology Allergy Cytology Aplastische Anämie Knochenmarkkrankheit Konferenzschrift 1987 Washington DC |
url | https://doi.org/10.1007/978-1-4612-3254-4 |
work_keys_str_mv | AT shahidinasrollaht aplasticanemiaandotherbonemarrowfailuresyndromes |